Avantor Investor Conference Presentation Deck

Attractive end markets provide long-term growth opportunities BIOPHARMA, HEALTHCARE, EDUCATION & GOVERNMENT XX ADVANCED MODALITIES Growing pipeline of cell & gene therapy, monoclonal antibodies, antibody-drug conjugates & multi- specific modalities 昆 PERSONALIZED MEDICINE Biomarker testing for personalized care AUTOMATION R&D complexity driving rapid scale-up and standardization 'OMICS' Multi-omics datasets to support drug discovery ADVANCED TECHNOLOGIES PFAS TESTING Regulations increasing demand for standards & reference materials Deepening focus on highest growth areas CLEAN ENERGY Electric vehicles driving demand for battery R&D, QA/QC and testing Navantor™ 12

View entire presentation